Base editing of angptl3 and methods of using same for treatment of disease

MYPI2026000070A0Undetermined Publication Date: 2021-10-09VERVE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026000070
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-01-11
Filing Date
2021-04-09
Publication Date
2021-10-09
Patent Text Reader

Abstract

Provided herein are compositions for gene modification or editing and methods of using same to treat or prevent certain conditions. Specific compositions and methods capable of safely and effectively editing gene targets expressed in the liver to durably lower LDL-C thereby treating a leading cause of cardiovascular disease are disclosed. FIG.49A
Need to check novelty before this filing date? Find Prior Art